Diagnostic kits

Tender description

Public Health England (PHE) is planning to award a contract for provision of unique kits for detection and resistance identification of GU diseases to SpeeDx Ltd. The requirement is for, but not limited to: — VHS (Varicella/Herpes/Syphilis) for diagnosis of genital ulcer disease, — ResistancePlus MG for macrolide resistance testing of MG screen positive samples, — ResistancePlus GC for ciprofloxacin sensitivity of GC NAAT positive sample, — unique software for analysis of different assays performed individually or simultaneously to help streamline workflow. The tests will be initially purchased for PHE Bristol but the contract covers all sites nationwide. The estimated initial volumes of VHS are around 10 000 tests per annum but are likely to increase. The volumes of ResistancePlus kits will depend on the diagnostic requirements.